The ROE as of December 2024 (TTM) for Avalo Therapeutics, Inc. (AVTX) is 42.52%

According to Avalo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 42.52%. This represents a change of -103.81% compared to the average of -1115.02% of the last 4 quarters.

Avalo Therapeutics, Inc. (AVTX) Historical ROE (quarterly & annually)

How has AVTX ROE performed in the past?

The mean historical ROE of Avalo Therapeutics, Inc. over the last ten years is -888.04%. The current 42.52% ROE has changed -104.79% with respect to the historical average. Over the past ten years (40 quarters), AVTX's ROE was at its highest in in the March 2017 quarter at 460.51%. The ROE was at its lowest in in the June 2024 quarter at -4577.55%.

Avalo Therapeutics, Inc. (AVTX) ROE by Quarter and Year

Discovering the peaks and valleys of Avalo Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Avalo Therapeutics, Inc. (AVTX) Average ROE

How has AVTX ROE performed in the past?

The current ROE of Avalo Therapeutics, Inc. (AVTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Avalo Therapeutics, Inc. (AVTX) ROE vs. Peers

How is AVTX’s ROE compared to its peers?

Avalo Therapeutics, Inc.’s ROE is greater than AnaptysBio, Inc. (-287.94%), greater than Arcellx, Inc. (-8.28%), greater than Structure Therapeutics Inc. (-16.40%), greater than Aerovate Therapeutics, Inc. (-90.19%), greater than ALX Oncology Holdings Inc. (-93.02%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.95%), greater than PMV Pharmaceuticals, Inc. (-24.20%), greater than Molecular Partners AG (-39.16%), greater than Mineralys Therapeutics, Inc. (-55.92%), less than Alzamend Neuro, Inc. (550.92%), greater than Virax Biolabs Group Limited (-115.10%), less than Kiromic BioPharma, Inc. (327.18%), greater than Benitec Biopharma Inc. (-60.28%), greater than Century Therapeutics, Inc. (-66.58%), greater than Edgewise Therapeutics, Inc. (-26.83%), greater than C4 Therapeutics, Inc. (-42.45%), greater than Cullinan Oncology, Inc. (-26.54%), greater than Miromatrix Medical Inc. (-70.01%), less than ZIVO Bioscience, Inc. (618.61%), greater than Bionomics Limited (-116.12%),

Build a custom stock screener for Avalo Therapeutics, Inc. (AVTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avalo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Avalo Therapeutics, Inc. (AVTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Avalo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.